In controlled laboratory systems, it binds and activates the GLP-1 receptor, a receptor system studied for its role in glucose homeostasis and appetite regulation pathways
Patients with Graves' disease may require Mounjaro for diabetes control or weight-related concerns, particularly following thyroid treatment
Examples Acarbose (Precose) Dosage Initial: 25 mg three times daily with first bite of each meal Maximum: Generally 300 mg, with meals, per day Miglitol (Glyset) Dosage Initial: 25 mg three times daily at the start of each meal Maximum: 50 mg three times daily Possible side effects include: Gastrointestinal: flatulence (gas), abdominal discomfort, diarrhea High-carbohydrate diet may worsen these side effects Gastrointestinal side effects usually become less pronounced with continued use Liver enzyme (transaminases) elevation Sulfonylureas Primary mechanism(s) of action Sulfonylureas stimulate insulin release by pancreatic beta cells
Dulaglutide The HR effects of dulaglutide 0.75 mg and 1.5 mg were investigated using ambulatory blood pressure and HR measurements in 505 subjects with T2DM following 26 weeks treatment [30]
PubMed laboratory research record [PMID: 41259764] PubMed record related to this compound for laboratory literature review
Development of peptide therapeutics: A nonclinical safety assessment perspective
